Medical Pharmaceutical Supply – Naloxone Hydrochloride
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract pertains to the supply of five packs containing a total of fifty units of Naloxone Hydrochloride 10 mg per 0.4 mL auto-injectors, all of which must meet stringent FDA regulatory standards, established shelf-life requirements, and Defense Logistics Agency medical specifications. These auto-injectors are intended for emergency opioid overdose reversal and must be fully compliant with federal medical procurement guidelines to ensure safety, efficacy, and reliability in critical situations. The contract is structured as a subcontract under the Department of Defense, specifically managed by the Defense Logistics Agency, and falls under the NAICS code 325412 for pharmaceutical and medicine manufacturing. The solicitation was posted on July 16, 2026, and the performance location and point of contact details are unspecified, though the award is accessible via the DIBBS system under contract number SPE2DP26P1016.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPE2DP-26-P-1016.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
NALOXONE HYDROCHLOR
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
